Biotech Startups
9,603 companies tagged Biotech, with their investors and founders.
La Vie Foods produces plant-based meat substitutes including bacon, ham, sausage, meatballs, sandwiches, and tofu for consumers seeking vegetarian and vegan alternatives. The company operates in the foodtech sector with products designed as direct replacements for traditional meat products.
4 investors
Latigo Bio is a clinical-stage biopharmaceutical company developing non-opioid pain medicines intended to block pain transmission without addiction risk. It targets the pain management therapeutic market in the United States.
4 investors
Laverock develops programmable engineered cell therapies that control gene expression based on cell identity and environment, activating only in the target cell population and tuning expression to precise levels. The company applies its gene-regulation platforms to an internal advanced therapy pipeline and pursues outlicensing and partnerships for additional therapeutic and non-therapeutic applications.
4 investors
Lenoss develops products aimed at advancing a physiological treatment pathway, supported by a team of industry professionals and clinical advisors. The company operates in the medical field with a focus on clinical treatment solutions.
4 investors
Leyden Labs develops nasal sprays containing antibodies that target respiratory viruses such as influenza and COVID at the nasal mucosa to prevent initial infection and transmission. The company works on broadly protective antiviral products aimed at addressing endemic and pandemic respiratory threats.
4 investors
LifeSprout develops synthetic materials that mimic the body's own tissues for aesthetic and regenerative medicine, creating products to treat patients with soft tissue loss from aging, cancer, and metabolic disease. It operates in the regenerative medicine and biomaterials category.
4 investors
Lucent Bio develops sustainable crop nutrition products, including its flagship Soileos micronutrient fertilizer made by upcycling pea, lentil, and oat hulls from food processing. The company serves farmers and food processors in the agri-food sector, with a focus on Canadian agriculture.
4 investors
Lucira Health manufactures portable diagnostic devices that connect to smartphones to test bodily fluids for infectious diseases, enabling rapid results outside of clinical settings.
4 investors
Lucy manufactures tobacco-free nicotine pouches in various flavors and strengths designed for consumer use. The products are marketed for enhancing focus, boosting energy, or relaxation.
4 investors
MacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.
4 investors
Mahzi develops therapies for patients with under-diagnosed and under-served rare genetic neurodevelopmental disorders, working with patient and family groups, academic researchers, and industry partners. The company operates across biopharmaceutical research, development, and manufacturing.
4 investors
Manifold provides an enterprise agent platform that uses agentic AI to accelerate drug discovery and development processes for life sciences companies, from early discovery through clinical stages.
4 investors
MantleBio provides a data management and analytics platform designed for biotech researchers and scientific teams. The platform integrates biological data, enables advanced bioinformatics analysis, and accelerates drug development and genomics research workflows.
4 investors
Matter Works builds AI tools to analyze and interpret biological data, accelerating scientific discovery in the life sciences. The company serves researchers and institutions across multiple life science disciplines.
4 investors
Maxwell Biosciences develops therapeutics aimed at treating infectious diseases. The company works with research and defense institutions on biodefense and antimicrobial-related work.
4 investors
MC10 developed conformal BioStamp wearable sensors and clinical analytics for physiological data capture in clinical research.
4 investors
Medcura develops hemostatic products made from hydrophobically modified biopolymers to control minimal, mild, and moderate surgical bleeding through mechanical mucoadhesion. Its offerings target surgeons, patients, and payers in the surgical hemostasis market, including specialized applications such as spine surgery.
4 investors
Medrio provides a no-code electronic data capture (EDC) platform for clinical trials, aimed at small and scaling life sciences sponsors and CRO teams. The platform lets teams configure and manage studies without programming, and offers services from clinical experts covering database build, data management, and biostatistical analysis.
4 investors
Lite Strategy, Inc. (NASDAQ: LITS) is a publicly traded treasury company that accumulates and manages Litecoin (LTC) holdings, aiming to increase LTC exposure per share for its shareholders. It positions itself as a way for public-market investors to gain exposure to Litecoin.
4 investors
Menten AI develops generative AI software to design cyclic peptide therapeutics for drug targets beyond the reach of conventional small molecules and biologics. The company partners with major pharmaceutical firms to accelerate preclinical drug discovery.
4 investors
Merus develops multispecific antibodies (Biclonics and Triclonics) that bind multiple cancer antigens to treat oncology indications. The company's lead candidate, petosemtamab, is in clinical development for head and neck cancer and colorectal cancer.
4 investors
Metabolon provides metabolomics services and bioinformatics tools that measure small molecules to give biological context to research data. It serves biopharma, public health, consumer wellness, agriculture, and academic research clients across discovery, clinical, and translational studies.
4 investors
Metcela develops cell-based medicines through research and development, focused on delivering new treatments for children and people affected by rare diseases.
4 investors
microTERRA develops functional food ingredients derived from Lemna (duckweed) that improve flavor and texture, offering a sustainable alternative to conventional ingredient sources. It serves the food industry, targeting formulators, creators, and distributors.
4 investors